Post Marketing Information DHCPL 18/05/2021 Interim authorisation of Pfizer-BioNTech COVID-19 Vaccine extended to include use in adolescents aged 12 to 15 years DHCPL 29/12/2020 Monitoring the safety profile of COVID-19 vaccines DHCPL 14/12/2020 Interim authorisation of Pfizer-BioNTech COVID-19 vaccine (BNT162b2) for active immunisation to prevent COVID-19 disease in Singapore
General Availability in Public Healthcare Institution Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration Comirnaty Injection (Multi-Dose Vial) 30 mcg/dose Alexandra Hospital
INTRAMUSCULAR Select a brand starting with the letter: C COMIRNATY ORIGINAL/OMICRON BA.4-5 CONCENTRATE FOR DISPERSION FOR INJECTION 1.5/1.5 MICROGRAMS/DOSE [SIN17053P] COMIRNATY ORIGINAL/OMICRON BA.4-5 CONCENTRATE FOR DISPERSION FOR INJECTION 5/5 MICROGRAMS/DOSE (MDV) [SIN16915P] COMIRNATY ORIGINAL/OMICRON BA.4-5 DISPERSION FOR INJECTION 15/15 MICROGRAMS/DOSE (MULTI-DOSE VIAL) [SIN16855P] See all COMIRNATY ORIGINAL/OMICRON BA.4-5 DISPERSION FOR INJECTION 15/15 MICROGRAMS/DOSE (SINGLE-DOSE VIAL) [SIN16856P] COMIRNATY ORIGINAL/OMICRON BA.4-5 DISPERSION FOR INJECTION 5/5 MICROGRAMS/DOSE (SINGLE-DOSE VIAL) [SIN17058P] COMIRNATY, CONCENTRATE FOR DISPERSION FOR INJECTION, 3 MICROGRAMS/DOSE [SIN16616P] COMIRNATY, DISPERSION FOR INJECTION, 10 MICROGRAMS/DOSE [SIN16397P] COMIRNATY, DISPERSION FOR INJECTION, 10 MICROGRAMS/DOSE (SINGLE-DOSE VIAL) [SIN17017P] COMIRNATY, DISPERSION FOR INJECTION, 30 MICROGRAMS/DOSE [SIN16396P] COMIRNATY, DISPERSION FOR INJECTION, 30 MICROGRAMS/DOSE (SINGLE-DOSE VIAL) [SIN17016P]